Search Results - "Pericas, M."

Inequalities in global health inequalities research: A 50-year bibliometric analysis (1966-2015) by Cash-Gibson, Lucinda, Rojas-Gualdrón, Diego F, Pericàs, Juan M, Benach, Joan

“…Increasing evidence shows that health inequalities exist between and within countries, and emphasis has been placed on strengthening the production and use of…”
Get full text

We know DAAs work, so now what? Simplifying models of care to enhance the hepatitis C cascade by Lazarus, J. V., Pericàs, J. M., Picchio, C., Cernosa, J., Hoekstra, M., Luhmann, N., Maticic, M., Read, P., Robinson, E. M., Dillon, J. F.

“…Globally, some 71 million people are chronically infected with hepatitis C virus (HCV). Marginalized populations, particularly people who inject drugs (PWID),…”
Get full text

A cross-sectional study of the public health response to non-alcoholic fatty liver disease in Europe by Lazarus, Jeffrey V., Ekstedt, Mattias, Marchesini, Giulio, Mullen, Jillian, Novak, Katja, Pericàs, Juan M., Roel, Elena, Romero-Gómez, Manuel, Ratziu, Vlad, Tacke, Frank, Cortez-Pinto, Helena, Anstee, Quentin M.

“…[Display omitted] •A comprehensive public health response to NAFLD is lacking in the 29 countries.•Major gaps include strategies, clinical guidelines,…”
Get full text

A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis by Harrison, Stephen A., Bedossa, Pierre, Guy, Cynthia D., Schattenberg, Jörn M., Loomba, Rohit, Taub, Rebecca, Labriola, Dominic, Moussa, Sam E., Neff, Guy W., Rinella, Mary E., Anstee, Quentin M., Abdelmalek, Manal F., Younossi, Zobair, Baum, Seth J., Francque, Sven, Charlton, Michael R., Newsome, Philip N., Lanthier, Nicolas, Schiefke, Ingolf, Mangia, Alessandra, Pericàs, Juan M., Patil, Rashmee, Sanyal, Arun J., Noureddin, Mazen, Bansal, Meena B., Alkhouri, Naim, Castera, Laurent, Rudraraju, Madhavi, Ratziu, Vlad

“…Resmetirom is a selective agonist of THR-β. In adults with nonalcoholic steatohepatitis and fibrosis, daily resmetirom (80 mg or 100 mg) was superior to…”
Get full text

Community-acquired pneumonia in critically ill very old patients: a growing problem by Cillóniz, Catia, Dominedò, Cristina, Pericàs, Juan M, Rodriguez-Hurtado, Diana, Torres, Antoni

“…Very old (aged ≥80 years) adults constitute an increasing proportion of the global population. Currently, this subgroup of patients represents an important…”
Get full text

COVID-19: from epidemiology to treatment by Pericàs, J M, Hernandez-Meneses, M, Sheahan, T P, Quintana, E, Ambrosioni, J, Sandoval, E, Falces, C, Marcos, M A, Tuset, M, Vilella, A, Moreno, A, Miro, J M

“…Abstract The COVID-19 pandemic has greatly impacted the daily clinical practice of cardiologists and cardiovascular surgeons. Preparedness of health workers…”
Get full text

Designing an exploratory phase 2b platform trial in NASH with correlated, co-primary binary endpoints by Meyer, Elias Laurin, Mesenbrink, Peter, Di Prospero, Nicholas A, Pericàs, Juan M, Glimm, Ekkehard, Ratziu, Vlad, Sena, Elena, König, Franz

“…Non-alcoholic steatohepatitis (NASH) is the progressive form of nonalcoholic fatty liver disease (NAFLD) and a disease with high unmet medical need. Platform…”
Get full text

Misconduct policies in high-impact biomedical journals by Bosch, Xavier, Hernández, Cristina, Pericas, Juan M, Doti, Pamela, Marušić, Ana

“…It is not clear which research misconduct policies are adopted by biomedical journals. This study assessed the prevalence and content policies of the most…”
Get full text

Machine-Learning Model for Mortality Prediction in Patients With Community-Acquired Pneumonia: Development and Validation Study by Cilloniz, Catia, Ward, Logan, Mogensen, Mads Lause, Pericàs, Juan M, Méndez, Raúl, Gabarrús, Albert, Ferrer, Miquel, Garcia-Vidal, Carolina, Menendez, Rosario, Torres, Antoni

“…Artificial intelligence tools and techniques such as machine learning (ML) are increasingly seen as a suitable manner in which to increase the prediction…”
Get full text

Key epidemiological indicators and spatial autocorrelation patterns across five waves of COVID-19 in Catalonia by Belvis, Francesc, Aleta, Alberto, Padilla-Pozo, Álvaro, Pericàs, Juan-M., Fernández-Gracia, Juan, Rodríguez, Jorge P., Eguíluz, Víctor M., De Santana, Charles Novaes, Julià, Mireia, Benach, Joan

“…This research studies the evolution of COVID-19 crude incident rates, effective reproduction number R(t) and their relationship with incidence spatial…”
Get full text

Prospective Cohort Study of Infective Endocarditis in People Who Inject Drugs by Pericàs, Juan M, Llopis, Jaume, Athan, Eugene, Hernández-Meneses, Marta, Hannan, Margaret M, Murdoch, David R, Kanafani, Zeina, Freiberger, Tomas, Strahilevitz, Jacob, Fernández-Hidalgo, Nuria, Lamas, Cristiane, Durante-Mangoni, Emanuele, Tattevin, Pierre, Nacinovich, Francisco, Chu, Vivian H, Miró, José M

“…Infective endocarditis (IE) in people who inject drugs (PWID) is an emergent public health problem. The purpose of this study was to investigate IE in PWID and…”
Get full text

High-Dose Daptomycin plus Fosfomycin Is Safe and Effective in Treating Methicillin-Susceptible and Methicillin-Resistant Staphylococcus aureus Endocarditis by MIRO, José M, ENTENZA, José M, MESTRES, Carlos A, ALMELA, Manuel, FALCES, Carlos, MARCO, Francesc, MOREILLON, Philippe, MORENO, Asuncion, ANA DEL RIO, VELASCO, Maria, CASTANEDA, Ximena, DE LA MARIA, Cristina Garcia, GIDDEY, Marlyse, ARMERO, Yolanda, PERICAS, Juan M, CERVERA, Carlos

“…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
Get full text

Platform trials to overcome major shortcomings of traditional clinical trials in non-alcoholic steatohepatitis? Pros and cons by Pericàs, Juan M., Tacke, Frank, Anstee, Quentin M., Di Prospero, Nicholas A., Kjær, Mette Skalshøj, Mesenbrink, Peter, Koenig, Franz, Genescà, Joan, Ratziu, Vlad

“…Non-alcoholic fatty liver disease is a condition that affects 25% of the population. Non-alcoholic steatohepatitis (NASH) is a progressive form of the disease…”
Get full text

Outcome of Enterococcus faecalis infective endocarditis according to the length of antibiotic therapy: Preliminary data from a cohort of 78 patients by Pericàs, Juan M, Cervera, Carlos, Moreno, Asunción, Garcia-de-la-Mària, Cristina, Almela, Manel, Falces, Carles, Quintana, Eduard, Vidal, Bàrbara, Llopis, Jaume, Fuster, David, Mestres, Carlos A, Marco, Francesc, Miró, Jose M

“…International guidelines recommend 4 weeks of treatment with ampicillin plus gentamicin (A+G) for uncomplicated native valve Enterococcus faecalis infective…”
Get full text

Lymphopenia Is Associated With Poor Outcomes of Patients With Community-Acquired Pneumonia and Sepsis by Cilloniz, Catia, Peroni, Héctor José, Gabarrús, Albert, García-Vidal, Carolina, Pericàs, Juan M, Bermejo-Martin, Jesús, Torres, Antoni

“…Lymphopenia is a marker of poor prognosis in patients with community-acquired pneumonia (CAP), yet its impact on outcomes in patients with CAP and sepsis…”
Get full text

Prevalence estimation of significant fibrosis because of NASH in Spain combining transient elastography and histology by Calleja, José L., Rivera‐Esteban, Jesús, Aller, Rocío, Hernández‐Conde, Marta, Abad, Javier, Pericàs, Juan M., Benito, Hugo G., Serra, Miguel A., Escudero, Amparo, Ampuero, Javier, Lucena, Ana, Sánchez, Yolanda, Arias‐Loste, María T., Iruzubieta, Paula, Romero‐Gómez, Manuel, Augustin, Salvador, Crespo, Javier

“…Background & Aims Non‐alcoholic fatty liver disease (NAFLD) has become a major public health problem, but the prevalence of fibrosis associated with…”
Get full text

The role of socio-demographic determinants in the geo-spatial distribution of newly diagnosed HIV infections in small areas of Catalonia (Spain) by Agustí, Cristina, Font-Casaseca, Núria, Belvis, Francesc, Julià, Mireia, Vives, Núria, Montoliu, Alexandra, Pericàs, Juan M, Casabona, Jordi, Benach, Joan

“…Spatial visualization of HIV surveillance data could improve the planning of programs to address the HIV epidemic. The objectives of the study were to describe…”
Get full text

Phenotypes of Metabolic Dysfunction–Associated Steatotic Liver Disease–Associated Hepatocellular Carcinoma by Rivera-Esteban, Jesús, Muñoz-Martínez, Sergio, Higuera, Mónica, Sena, Elena, Bermúdez-Ramos, María, Bañares, Juan, Martínez-Gomez, María, Cusidó, M. Serra, Jiménez-Masip, Alba, Francque, Sven M., Tacke, Frank, Minguez, Beatriz, Pericàs, Juan M.

“…Hepatocellular carcinoma (HCC) typically develops as a consequence of liver cirrhosis, but HCC epidemiology has evolved drastically in recent years. Metabolic…”
Get full text

Evaluation of the effectiveness and equity of the maternity protection reform in Chile from 2000 to 2015 by Delgado, Iris, Cabieses, Baltica, Apablaza, Mauricio, Castillo, Carla, Aguilera, Ximena, Matute, Isabel, Najera, Manuel, Pericàs, Juan M, Benach, Joan

“…According to the International Labor Organization, Maternity Protection (MP) policies try to harmonize child care and women's paid work, without affecting…”
Get full text

A roadmap for clinical trials in MASH-related compensated cirrhosis by Pericàs, Juan M., Anstee, Quentin M., Augustin, Salvador, Bataller, Ramón, Berzigotti, Annalisa, Ciudin, Andreea, Francque, Sven, Abraldes, Juan G., Hernández-Gea, Virginia, Pons, Mònica, Reiberger, Thomas, Rowe, Ian A., Rydqvist, Peter, Schabel, Elmer, Tacke, Frank, Tsochatzis, Emmanuel A., Genescà, Joan

“…Although metabolic dysfunction-associated steatohepatitis (MASH) is rapidly becoming a leading cause of cirrhosis worldwide, therapeutic options are limited…”
Get full text